Pandemic Incident Management for Vaccine Safety Challenges: Victoria's Alert Advisory Group Experience

被引:1
|
作者
Clothier, Hazel J. [1 ,2 ,3 ,4 ]
Wolthuizen, Michelle [3 ]
Laemmle-Ruff, Ingrid [2 ]
Lewis, Georgina [2 ]
Radkowski, Catherine [5 ]
Buttery, Jim [1 ,2 ,3 ,4 ,6 ]
Crawford, Nigel [2 ,3 ,4 ,6 ]
机构
[1] Melbourne Childrens Campus, Ctr Hlth Analyt, Epi Informat, Parkville, Vic, Australia
[2] Murdoch Childrens Res Inst, Surveillance Adverse Events Following Vaccinat Com, Melbourne, Vic, Australia
[3] Dept Hlth Victoria, COVID 19 Response, Melbourne, Australia
[4] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia
[5] Dept Hlth Victoria, Immunisat Unit, Melbourne, Australia
[6] Royal Childrens Hosp, Dept Gen Med, Infect Dis, Melbourne, Vic, Australia
关键词
biosecurity; vaccine safety; immunization; surveillance; incident control; pandemic; EVENTS FOLLOWING IMMUNIZATION; SURVEILLANCE; HEALTH;
D O I
10.1017/dmp.2024.100
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Safe vaccines are critical for biosecurity protection, yet adverse events-rightly or wrongly attributed to immunization-potentially cause rapid loss of confidence, reduced vaccine uptake, and resurgence of preventable disease. Effective vaccine safety incident management is essential to provide assessment and lead appropriate actions to ensure vaccination programs are safe and mitigate unwarranted crisis escalation that could damage vaccine programs and the effective control of vaccine preventable disease outbreaks or pandemics. Incident management systems (IMS) are used globally to direct emergency management response, particularly for natural disasters of fire, flood, and storm. Public health is equally an emergency response and can therefore benefit from these command control constructs. While examples of IMS for outbreak response and mass immunization logistics exist, there is little to no information on their use in vaccine safety. We describe Australia's vaccine safety Alert Advisory Group establishment in Victoria during the COVID-19 pandemic and onward embedding into routine practice, anticipant of new vaccines, and the next biosecurity threat.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Incorporating work experience of medical staff into patient safety climate management: a multi-group analysis
    Seung-Hwan Kim
    Shao-Jen Weng
    BMC Health Services Research, 18
  • [42] Management of pregnant women during the COVID-19 pandemic and experience in a Coruia's hospital
    Suarez Lavandeira, Tania
    Vazquez Diaz, Cristina
    Legazpi Fernandez, Rocio
    Peteiro Mahia, Laura
    REVISTA ROL DE ENFERMERIA, 2023, 46 (01): : 34 - 39
  • [43] Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccine
    Serra, Lidia
    Webber, Chris
    Burman, Cindy
    Bueti, Patrizia
    Gorruso, Maria
    Mather, Susan
    VACCINE, 2022, 40 (49) : 7014 - 7021
  • [44] A review of the COVID-19 pandemic's effects and challenges on worldwide waste management for sustainable development
    Abbasi, S.
    Sicakyuz, C.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL SCIENCE AND TECHNOLOGY, 2024, 21 (12) : 8231 - 8260
  • [45] Impact on Fatality Rates and Years of Life Lost During the COVID-19 Pandemic: The Experience of the Mexican Public Health Incident Management Command
    Duque-Molina, Celida
    Garcia-Rodriguez, Gabriel
    Zaragoza-Jimenez, Christian Arturo
    de la Torre-Rosas, Alethse
    Herrera-Canales, Michelle
    Loera-Rosales, Miriam Jackeline
    Perez-Cardoso, Ana Luisa
    Villa-Reyes, Tania
    Romo-Rodriguez, Rubi
    Sanchez-Morales, Sofhya Marylett
    Contreras-Hernandez, Iris
    Rivas-Ruiz, Rodolfo
    Castro-Escamilla, Octavio
    Ferat-Osorio, Eduardo
    Berlanga-Taylor, Antonio J.
    Pelayo, Rosana
    Robledo-Aburto, Zoe
    Bonifaz, Laura C.
    Alcocer-Varela, Jorge
    ARCHIVES OF MEDICAL RESEARCH, 2025, 56 (01)
  • [46] The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience
    Van Den Ende, Caroline
    Marano, Cinzia
    Van Ahee, Ayla
    Bunge, Eveline M.
    De Moerlooze, Laurence
    EXPERT REVIEW OF VACCINES, 2017, 16 (08) : 811 - 832
  • [47] Safety profile of the HPV vaccine. Six-year experience in Argentina's National Immunization Schedule
    Katz, N.
    Biscayart, C.
    Neyro, S.
    Stecher, D.
    Rancano, C.
    Juarez, M. D. V.
    Pasinovich, M.
    Devoto, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 356 - 356
  • [48] Importance of Vaccine Safety in Children with Chronic Conditions Experience at the Scientific Centre for Children's Health in Moscow, Russia
    Grechukha, Tatiana A.
    Galitskaya, Marina G.
    Namazova-Baranova, Leyla S.
    CURRENT DRUG SAFETY, 2015, 10 (01) : 49 - 54
  • [49] SAFETY OF THE ZOSTER RECOMBINANT ADJUVANTED VACCINE IN RHEUMATOID ARTHRITIS PATIENTS: A SINGLE CENTER'S EXPERIENCE WITH 300 PATIENTS
    Stevens, Emma
    Weinblatt, Michael E.
    Massarotti, Elena
    Griffin, Frances
    Desai, Sonali
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 695 - 695
  • [50] Developing a User's Group (UG) as a Natural Offshoot of Established Transfusion Safety Officer (TSO) and Patient Blood Management (PBM) Programs: Our Blood Center's Experience
    Gammon, R. R.
    Gilbert, D.
    Reik, R. A.
    Leparc, G. F.
    TRANSFUSION, 2014, 54 : 239A - 239A